Whole-brain mapping reveals the divergent impact of ketamine on the dopamine system
Cell Reports · 2023
DOI: 10.1016/j.celrep.2023.113491 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Malika S Datta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Columbia University, New York, NY 10027, USA; Mortimer B. Zuckerman Mind Brain and Behavior Institute, Columbia Un…. Hauptthemen laut MEDLINE: Ketamine. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIMH NIH HHS, National Institutes of Health, Columbia University.
Abstract (Originalsprache)
Ketamine is a multifunctional drug with clinical applications as an anesthetic, pain management medication, and a fast-acting antidepressant. However, it is also recreationally abused for its dissociative effects. Recent studies in rodents are revealing the neuronal mechanisms mediating its actions, but the impact of prolonged exposure to ketamine on brain-wide networks remains less understood. Here, we develop a sub-cellular resolution whole-brain phenotyping approach and utilize it in male mice to show that repeated ketamine administration leads to a dose-dependent decrease in dopamine neurons in midbrain regions linked to behavioral states, alongside an increase in the hypothalamus. Additionally, diverse changes are observed in long-range innervations of the prefrontal cortex, striatum, and sensory areas. Furthermore, the data support a role for post-transcriptional regulation in enabling ketamine-induced neural plasticity. Through an unbiased, high-resolution whole-brain analysis, this study provides important insights into how chronic ketamine exposure reshapes brain-wide networks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Columbia University, New York, NY 10027, USA; Mortimer B. Zuckerman Mind Brain and Behavior Institute, Columbia University, New York, NY 10027, USA.
- Department of Biological Sciences, Columbia University, New York, NY 10027, USA; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.
- Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
- Department of Biological Sciences, Columbia University, New York, NY 10027, USA; Mortimer B. Zuckerman Mind Brain and Behavior Institute, Columbia University, New York, NY 10027, USA; Department of Biomedical Engineerin…
Förderung
- NIMH NIH HHS
- National Institutes of Health
- Columbia University
- OpenAI
Zitieren
APA
Datta, M. S., Chen, Y., Chauhan, S., Zhang, J., De La Cruz, E. D., Gong, C., & Tomer, R. (2023). Whole-brain mapping reveals the divergent impact of ketamine on the dopamine system. Cell Reports. https://doi.org/10.1016/j.celrep.2023.113491
Vancouver
Datta MS, Chen Y, Chauhan S, Zhang J, De La Cruz ED, Gong C, et al. Whole-brain mapping reveals the divergent impact of ketamine on the dopamine system. Cell Reports. 2023. doi:10.1016/j.celrep.2023.113491
BibTeX
@article{Datta2023,
author = {Datta, Malika S and Chen, Yannan and Chauhan, Shradha and Zhang, Jing and De La Cruz, Estanislao Daniel and Gong, Cheng and Tomer, Raju},
title = {Whole-brain mapping reveals the divergent impact of ketamine on the dopamine system},
journal = {Cell Reports},
year = {2023},
doi = {10.1016/j.celrep.2023.113491}
}
EUVIMED